Zacks Small Cap Weighs in on Spectral AI Q2 Earnings

Spectral AI, Inc. (NASDAQ:MDAI) – Equities research analysts at Zacks Small Cap issued their Q2 2025 earnings per share (EPS) estimates for Spectral AI in a research note issued on Monday, May 19th. Zacks Small Cap analyst J. Vandermosten forecasts that the company will post earnings of ($0.06) per share for the quarter. The consensus estimate for Spectral AI’s current full-year earnings is ($0.48) per share. Zacks Small Cap also issued estimates for Spectral AI’s Q4 2025 earnings at ($0.09) EPS, FY2026 earnings at ($0.20) EPS and FY2027 earnings at ($0.09) EPS.

Spectral AI (NASDAQ:MDAI) last released its quarterly earnings results on Thursday, March 27th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.07. The firm had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.83 million.

A number of other brokerages have also recently issued reports on MDAI. Wall Street Zen upgraded Spectral AI from a “sell” rating to a “hold” rating in a report on Thursday. HC Wainwright restated a “buy” rating and set a $3.50 price objective on shares of Spectral AI in a report on Wednesday, April 2nd.

Spectral AI Stock Down 0.7%

Shares of NASDAQ MDAI opened at $1.37 on Thursday. The business’s 50 day moving average price is $1.30 and its two-hundred day moving average price is $1.68. The company has a market cap of $34.68 million, a PE ratio of -2.11 and a beta of 0.59. Spectral AI has a twelve month low of $0.82 and a twelve month high of $3.25.

Institutional Trading of Spectral AI

A number of institutional investors have recently bought and sold shares of MDAI. Virtu Financial LLC bought a new position in Spectral AI in the 4th quarter valued at about $38,000. Northern Trust Corp purchased a new stake in Spectral AI in the 4th quarter valued at about $44,000. Millington Financial Advisors LLC purchased a new stake in Spectral AI in the 4th quarter valued at about $85,000. Jane Street Group LLC purchased a new stake in Spectral AI in the 4th quarter valued at about $92,000. Finally, Avantax Planning Partners Inc. increased its stake in Spectral AI by 44.7% in the 4th quarter. Avantax Planning Partners Inc. now owns 231,336 shares of the company’s stock valued at $655,000 after buying an additional 71,484 shares during the last quarter. Institutional investors own 67.08% of the company’s stock.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.